Purpose: To assess long-term efficacy and safety of self-made cryopreservative fibrin glue (SMC) applied in pterygium surgery. Methods: Prospective, comparative, interventional case series. Forty eyes of 40 patients with nasal primary pterygium, 24 male and 16 female, were enrolled. The patients were assigned to two groups and each contained 12 male and eight female based on the pterygium area encroaching onto the cornea. In one group, the conjunctival autograft was attached to the sclera with SMC stored for 2 months, and in the other group, commercial fibrin glue kit (CK) was applied after the pterygium was removed. All the patients were followed up postoperatively on days 1, 3, 7 and 14 then at months 1, 3, 6, 12. The main outcome measures included operating time, postoperative discomfort, recurrence rate and complications. Results: There were no significant differences in surgery time (p = 0.713) and postoperative discomfort (day 1, 3, 7; p = 0.747, p = 0.766, p = 0.983, respectively) between the two groups. By the end of 1-year follow-up, the recurrence rate was 0% in the SMC group and 5% in the CK group (p = 1.000). There were no infections and severe visual acuity (VA) threatening complications in either group. Conclusion: Self-made cryopreservative fibrin glue (SMC) is as effective as standard CK for autograft fixation in pterygium surgery and it also has good safety after long-term follow-up. For its convenience and low cost, this new methods should be popularized, especially in underdeveloped area.
Introduction
Fixation of limbal conjunctival autograft with fibrin glue can authentically be stated as the preferred choice for pterygium surgery today. It causes much fewer postoperative discomforts, shortens surgery time and is with lower recurrence rates and fewer complications compared with traditional suture method (Koranyi et al. 2004 (Koranyi et al. , 2013 Uy et al. 2005; Bahar et al. 2006; Jiang et al. 2008 Jiang et al. , 2015 Hall et al. 2009; Cha et al. 2012; Cagatay et al. 2014) . Commercial fibrin glue kit (CK) such as Tisseel is usually used for conjunctival autograft fixation during pterygium surgery. Although it works efficiently, there are still several disadvantages. Firstly, commercial kit might not be got in each country or region; secondly, the cost of kit is not low and thirdly, it needs 15-30 min to prepare the two components of fibrin glue and they can only be placed at room temperature for several hours.
Recently, to improve these disadvantages mentioned above, we have reported a new technique of SMC used in pterygium surgery and got satisfying results during short-term follow-up.
This prospective study was designed to compare the long-term efficacy and safety between SMC and CK in pterygium surgery aiming to find out which method is truly better under comprehensive assessment.
Patients and Methods
From 1 Jan to 31 Mar 2015, 40 patients with primary nasal pterygium who wanted to be treated by surgery were prospectively enrolled. Among them, 24 were male and the other 16 were female. A detailed medical and ocular history was obtained, including patient age, gender and family as well as medical, systemic and ocular history. The first time the patient had found the pterygium was also recorded. Snellen VA measurement, funduscopy, applanation tonometry and slit-lamp examination were performed preoperatively. Patients with ocular pathology other than early stage of cataract, mild dryness of eye, error of refraction, with a history of previous ocular surgery or trauma or with severe systemic diseases were excluded. Informed consent was obtained from all patients. This study was approved by the research ethics committees of Zhejiang Provincial People' Hospital and adhered to the tenets of the Declaration of Helsinki.
Pterygium measurement and patient grouping
The portion of pterygium encroaching onto the cornea is similar in shape to a triangle. Therefore, its area can approximately be calculated by the following formula: Area = Base (length of intersection line between limbus and pterygium) 9 Height (length of vertical line from the apex of pterygium to the Base)/ 2. The length was measured with a compass, and then, numerical values were obtained with a ruler.
The area data collected from the 24 male patients were sorted in descending order and numbered from 1 to 24. Every two numbers constituted a study pair, so that was (1 and 2), (3 and 4) . . . (23 and 24). Which one in the pair entered the SMC group was decided by tossing a coin and the left entered the CK group. The 16 female patients were assigned into two groups with the same method. Ultimately there were 20 patients, 12 male and eight female, in each group.
Fibrin glue preparation

CK
The two components of fibrin sealant (RAAS Blood Products, Shanghai, China), fibrinogen and thrombin, were prepared by an assistant after the patient entered the operation room according to the instructions.
SMC
Human Fibrinogen 0.5 g (Boya BioPharmaceutical, Jiangxi, China) dissolved in sterile water for injection with concentration of 60 mg/ml. Lyophilizing Thrombin Powder 500 IU (Yige Pharmaceutical, Hunan, China) dissolved in 40 mmol/l CaCl 2 with concentration of 500 IU/ml. These two components then were separately subpacked into 1-ml Eppendorf tubes and stored at À20°C for 2 months. One tube of fibrinogen solution and one tube of thrombin solution would be brought into operation room with each patient.
Surgery process
One experienced surgeon performed all surgeries. The involved eye underwent standard sterile preparation and draping. Under local anaesthesia with 0.4% oxybuprocaine hydrochloride (Benoxil, Santen, Osaka, Japan), the keratinized head of the pterygium was dissected from the cornea until to the limbus using a surgical blade, and then, this portion was excised. A lidocaine-epinephrine mixed solution was injected into the pterygium body to balloon out the conjunctiva, after that the subconjunctival fibrovascular tissue was exposed by blunt and sharp dissection, and at the same time, the pterygium was also separated from the underlying sclera until near to the insertion of medial rectus. The residual pterygium and surrounding atrophic conjunctival tissue were then excised. The wound bed was scraped to clean cornea and sclera, and only bleeding vessels were cauterized.
The dimensions of the bare sclera bed were measured with a compass, and a free graft with an additional 1.0 mm of length and width was then obtained from the superotemporal bulbar conjunctiva. Care was taken to include as little as possible of Tenon's tissue under the graft and the limbal side of the graft contained a thin rim of corneal epithelium.
It was not until the graft was harvested that the surgeon was told which kind of fibrin glue would be used in next step.
In both CK and SMC groups, the glue was applied in the same way. One drop of the fibrinogen component was placed on the scleral bed, and then, one drop of the thrombin component was applied to active the sealant. The graft was spread over the sclera with care taken to maintain the right orientation and not to turn over the epithelial and stromal faces of the conjunctiva. The free edges of the nasal primary conjunctiva were attached to the sclera below too. Excess glue was removed, and the graft was trimmed if necessary. After a drying period of 1 min, the lid retractors were removed.
Tobramycin-dexamethasone ointment was applied into conjunctiva sac, and a pressure patch was applied for 24 hr to restrict the eyeball from movement or blinking. From the second day on, tobramycin and dexamethasone eye drops were applied four times daily and tapered off over the following month.
Study and follow-up project
Surgery time was recorded from the placement of the lid speculum to its removal. All the patients were followed up postoperatively on days 1, 3, 7 and 14 and at months 1, 3, 6, 12. In addition, during this period, they were required to see the doctor at the time any conjunctival tissue was found to have grown onto the cornea again.
Snellen VA and intraocular pressure (IOP) were tested at each visit. The slitlamp examination was performed to observe the integrity and position of graft, carefully looking for any evidence of recurrence or complications. A questionnaire was designed to record the patients' subjective symptoms including tearing, pain and foreign body sensation in both groups during the first week follow-up. The overall discomfort was evaluated by a 4-point scale: (0) none; (1) somewhat bothersome; (2) quite bothersome; (3) very bothersome.
Statistics
The paired-sample t-test was used to compare the surgery time. The two independent samples Mann-Whitney U-test was used to analyse the differences in postoperative symptom scores between the two groups. The chi-square test was used to evaluate the differences in pterygium recurrence and various complications. Value was taken to be statistically significant at p < 0.05.
Results
There were no significant differences between the two groups for ethnicity, level of education or occupation. There were also no statistically significant differences in age, area encroaching onto the cornea or the years of pterygium history (p = 0.647, p = 0.475, and p = 0.686, respectively; Table 1 ).
Mean surgery time was 18.6 AE 2.4 min for the SMC group and 18.9 AE 3.0 min for the CK group, and no significant difference was found (p = 0.713). There were also no significant differences in postoperative discomfort scores between the two groups on all follow-up days (day 1, 3, and 7; U = 188.5, p = 0.747; U = 190.0, p = 0.766; U = 199.5, p = 0.983, respectively; Fig. 1 ).
All the patients completed the 1-year follow-up. In both groups, a yellowish graft oedema could be observed in some eyes in the first few days postoperatively, and it resolved gradually and spontaneously. The donor site healed well in every case within 14 days, making it possible for future ocular surgery if required. By the end of the first month, all the grafts were intact and maintained in the primary position except one in SMC group (Fig. 2) . It was on follow-up day 3 that we found the graft curled in its inferior part, and the sclera was exposed. No obvious discomfort was complained. The patient recalled that he had ever rubbed his eye carelessly. It seemed unlikely that it would heal without intervention. Then, under topical anaesthesia, the graft was stuck again with SMC and it grew well from then on. No cases of infection, conjunctival cyst, symblephara, scleral thinning, necrosis or severe VA threatening complications were observed in either group (Table 2) .
At 1 year, there was no recurrence in the SMC group but 1 recurrence (5%) in the CK group found in month 3. There was no significant difference in recurrences between the two groups (p = 1.000; Table 2 ).
Discussion
The use of limbal conjunctival autograft in pterygium surgery is based on the theory of restoring the anatomic integrity of the limbus and addressing limbal stem cell deficiency (Tseng 1989; Al Fayez 2002) . It is currently the method most commonly used. Early surgeons fixed the autograft with sutures. However, the success rate of suture fixed conjunctival autograft and the required surgery time varies widely among different surgeons. In addition, suturing is associated with some discomfort and complications such as granuloma and graft dehiscence.
In 2004, Koranyi, first reported a 'Cut and Paste' method in pterygium surgery with fibrin glue kit (Tisseel Duo Quick, Baxter; Koranyi et al. 2004 ). They concluded the new method caused much fewer postoperative symptoms and shortened surgery time significantly, and the long-term results were also satisfying. Since then, many researches were carried out and repeatedly confirmed the superiority of fibrin glue kit over suture (Uy et al. 2005; Bahar et al. 2006; Jiang et al. 2008; Hall et al. 2009; Cha et al. 2012; Cagatay et al. 2014) .
But in reality, commercial kit might not be got in each country or region, especially those underdeveloped. Moreover, the cost of kit is not low. In previous short-term observational studies, we compared SMCs with different storage time of 3 days, 7 days, 15 days, 1 m, 2 m and 3 m in safety and efficacy. At each time point, the asepsis of SMC was confirmed by bacterial culture and colony counting. The results indicated no colony growth was observed in all the fibrinogen and thrombin tubes sent. All groups of SMC could effectively adhere the autograft to bare sclera in pterygium surgery. By the end of 6 m follow-up, no infections and severe complications were observed in any group. The total recurrence rate was 3/48 (6%) (Gong Jingwen et al. unpublished) . Considering the possible monthly surgery volume and the safety, we chose SMC 2 m as experiment group in current study.
We compared SMC with CK to assess its long-term safety and efficacy. We considered different sizes of the pterygium area encroaching onto the cornea would lead to differences in the required surgery time for dissection from the cornea, and that gender would influence postoperative experience of discomfort, so when we performed the grouping, the encroached area and gender were controlled.
According to the results of the study, SMC stored for 2 months was as excellent as standard CK in fixing autograft, shortening surgery time and lessening postoperative discomforts. No infection and severe complications were observed in SMC group during the 1-year followup. We expected the long-term recurrence rate for the SMC group to be similar to that of CK group, and it turned out to be 0/20 (0%). There was no statistically significant difference between the two groups. The small size of the samples may be a limitation of this study, and a large-size study is now in progress.
During the follow-up, graft moving was found in only one case. It might be for personal reason that the patient ever rubbed his eye carelessly in the immediate postoperative period. Before removal of lid retractors, we usually would ask every patient to rotate eye for several times to ensure the graft was well stuck; otherwise, fibrin glue would be used again. Maybe a pressure patch applied for 48 hr would help reduce the accident. Considering that blood product may carry the theoretical risk of transmitting infectious agents (Ti et al. 2000; Foroutan et al. 2011 ) and the high cost associated with fibrin glue kit (Koranyi et al. 2004) , another interesting method of autologous blood for conjunctival autograft fixation has been introduced in recent years. Autologous blood was used instead of sutures or fibrin glue in pterygium surgery. The results showed this method was more effective in small-size pterygium than larger one. Meanwhile, it was less stable and took more surgery time compared with commercial fibrin glue (Sharma & Moore 2009; de Wit et al. 2010; Singh et al. 2013; Boucher et al. 2015) .
In our study, no virus infection and anaphylactic reactions were found in both groups during the whole followup. The price of Human Fibrinogen 0.5 g is about 4/5 of that of CK. Compared to the fibrinogen component (2 ml) in CK, Human Fibrinogen 0.5 g used in this study can dissolved in 8-10 ml sterile water. In each pterygium surgery, one to two drops (50-100 Àll) of fibrinogen mixed with one to two drops of thrombin are enough to make a good fixation. If we prepared 0.5 ml per tube for each patient, one bottle of Human Fibrinogen 0.5 can be used for 16-20 patients. Then, the mean cost of the material will be affordable and even cheaper than a suture. Being stored at À20°C in Eppendorf tube, SMC can be taken out and applied in pterygium surgery at any time within 3 months. In addition, it certainly can be handily carried to nearby hospital or heath centre in an ice box.
In conclusion, SMC is as effective as standard CK for autograft fixation in pterygium surgery. There were no infections and severe related complications after long-term follow-up. Being repacked, the cost of SMC on each patient is much lower than that of CK. Further evaluation of the safety and recurrence rate will be carried out with a larger series. 
